Market Research Logo

Global Immunohistochemistry Market Forecast 2018-2026

Global Immunohistochemistry Market Forecast 2018-2026

KEY FINDINGS

Immunohistochemistry is a comprehensive phrase, integrating biochemical, immunological, and anatomical procedure to visualize and constrain individually separated constituents in tissues by interacting with the antibodies-antigen. The market is anticipated to develop at 7.93% of CAGR throughout the forecasting years.

MARKET INSIGHTS

The growing geriatric population along with the augmenting healthcare expenditure are some of the key factors driving the global immunohistochemistry market. The market segmentation includes product, application, and end-user. In the product market, reagents segment is evolving at a significant pace during the forecast period. The reagents segment of the product market includes histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents, stabilizers, organic solvents, proteolytic enzymes, and diluents. The diagnostics is the fastest growing segment in the application market. Moreover, diagnostic laboratories and hospitals dominate by holding the highest share in the end-user market. Nevertheless, growing undiagnosed populace with no insurance cover is one of the major factor declining the growth of the market across the globe.

REGIONAL INSIGHTS

The global immunohistochemistry market comprises of four major regions such as North America, Europe, Asia-Pacific, Latin America, and rest of world. North America region dominates the global market, majorly attributed to the developed countries like the United States and Canada. Moreover, the Asia Pacific region is evolving at a significant pace over the forecasting years. The growing cases of cancer is the major reason driving the market growth in this region.

COMPETITIVE INSIGHTS

The leading players in the market are Abbott Laboratories, Abcam Plc, Agilent Technologies, Inc., Biogenex, Bio-Rad Laboratories, Inc., Bio Sb, Cell Signaling Technology, Inc., Danaher Corporation, F. Hoffmann-La Roche Ag, Histologix, Merck Millipore, Perkinelmer, Inc., Siemens Ag Healthcare, and Thermo Fisher Scientific Inc.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. North America Dominated The Immunohistochemistry Market
3.2.2. Reagents Products Are Growing At A Significant Rate
3.2.3. Diagnostics Is The Most Widely Used Application In The Market
3.2.4. Hospitals And Diagnostic Laboratories Holds The Largest Market Share In The End-users Market
4. Market Determinants
4.1. Market Drivers
4.1.1. Rising Cancer Incidence
4.1.2. Technological Expansions In In-vitro Diagnostic Commerce
4.1.3. Increasing Elderly Population
4.1.4. Increasing Healthcare Spending
4.1.5. Growing Popularity Of Poc Testing
4.2. Market Restraints
4.2.1. Insurance Coverage And Reimbursement Issues
4.2.2. Limitations Of Closed Systems
4.2.3. Presence Of An Undiagnosed Population
4.3. Market Opportunities
4.3.1. Use Of Biomarkers For Disease Diagnosis And Increasing Efficiency
4.3.2. Paradigm Shift Toward Precision Diagnosis Through Personalized Medicine
4.3.3. Advancements In Technologies
4.4. Market Challenges
4.4.1. High Initial Investment And Maintenance Cost
4.4.2. Stringent Regulation For Approval Of Devices
4.4.3. Pricing Pressure Coupled With Lack Of Product Differentiation
5. Market Segmentation
5.1. Market By Products 2018-2026
5.1.1. Antibodies
5.1.1.1. Primary Antibodies
5.1.1.2. Secondary Antibodies
5.1.2. Equipment
5.1.2.1. Slide Staining Systems
5.1.2.2. Tissue Microarrays
5.1.2.3. Tissue Processing Systems
5.1.2.4. Slide Scanners
5.1.2.5. Other Equipments
5.1.3. Reagents
5.1.3.1. Histological Stains
5.1.3.2. Blocking Sera And Reagents
5.1.3.3. Chromogenic Substrates
5.1.3.4. Fixation Reagents
5.1.3.5. Stabilizers
5.1.3.6. Organic Solvents
5.1.3.7. Proteolytic Enzymes
5.1.3.8. Diluents
5.1.4. Kits
5.2. Market By Applications 2018-2026
5.2.1. Diagnostics
5.2.1.1. Cancer
5.2.1.2. Infectious Diseases
5.2.1.3. Cardiovascular Disease
5.2.1.4. Autoimmune Diseases
5.2.1.5. Diabetes Mellitus
5.2.1.6. Nephrological Diseases
5.2.2. Drug Testing
5.3. Market By End-users 2018-2026
5.3.1. Hospitals And Diagnostic Laboratories
5.3.2. Research Institutes
5.3.3. Other End-users
6. Key Analytics
6.1. Immunohistochemistry Etymology
6.2. Regulatory Frameworks
6.2.1. Regulations In The United States
6.3. Value Chain Analysis
6.3.1. Raw Material Suppliers
6.3.2. Manufacturers
6.3.3. Distributors
6.3.4. End-users
6.4. Opportunity Matrix
7. Geographical Analysis
7.1. North America
7.1.1. The United States
7.1.2. Canada
7.2. Europe
7.2.1. The United Kingdom
7.2.2. France
7.2.3. Germany
7.2.4. Spain
7.2.5. Italy
7.2.6. Russia
7.2.7. Rest Of Europe
7.3. Asia-pacific
7.3.1. China
7.3.2. India
7.3.3. Japan
7.3.4. South Korea
7.3.5. Australia
7.3.6. Rest Of Apac
7.4. Latin America
7.4.1. Brazil
7.4.2. Mexico
7.4.3. Argentina
7.4.4. Chile
7.4.5. Cuba
7.4.6. Rest Of Latin America
7.5. Rest Of World
7.5.1. Middle East And North Africa
7.5.2. Rest Of Africa
8. Company Profiles
8.1. Abbott Laboratories
8.1.1. Company Profile
8.1.2. Product Portfolio
8.1.3. Swot Analysis
8.1.4. Strategic Initiatives
8.2. Abcam Plc
8.2.1. Company Overview
8.2.2. Product Portfolio
8.2.3. Strategic Initiatives
8.3. Agilent Technologies, Inc.
8.3.1. Company Overview
8.3.2. Product Portfolio
8.3.3. Scot Analysis
8.3.4. Strategic Initiatives
8.4. Biogenex
8.4.1. Company Overview
8.4.2. Product Portfolio
8.4.3. Strategic Initiatives
8.5. Bio-rad Laboratories, Inc.
8.5.1. Company Overview
8.5.2. Product Portfolio
8.5.3. Scot Analysis
8.5.4. Strategic Initiative
8.6. Bio Sb
8.6.1. Company Overview
8.6.2. Product Portfolio
8.6.3. Strategic Initiatives
8.7. Cell Signaling Technology, Inc.
8.7.1. Company Overview
8.7.2. Product Portfolio
8.7.3. Scot Analysis
8.7.4. Strategic Initiatives
8.8. Danaher Corporation
8.8.1. Company Overview
8.8.2. Product Portfolio
8.8.3. Scot Analysis
8.8.4. Strategic Initiatives
8.9. F. Hoffmann-la Roche Ag
8.9.1. Company Overview
8.9.2. Product Portfolio
8.9.3. Scot Analysis
8.9.4. Strategic Initiatives
8.10. Histologix
8.10.1. Company Overview
8.10.2. Product Portfolio
8.11. Merck Millipore
8.11.1. Company Overview
8.11.2. Product Portfolio
8.11.3. Strategic Initiatives
8.12. Perkinelmer, Inc.
8.12.1. Company Overview
8.12.2. Product Portfolio
8.12.3. Scot Analysis
8.12.4. Strategic Initiatives
8.13. Siemens Ag Healthcare
8.13.1. Company Overview
8.13.2. Product Portfolio
8.13.3. Scot Analysis
8.13.4. Strategic Initiatives
8.14. Thermo Fisher Scientific Inc.
8.14.1. Company Overview
8.14.2. Product Portfolio
8.14.3. Scot Analysis
8.14.4. Strategic Initiatives
Table List
Table 1 Global Immunohistochemistry Market By Geography 2018-2026 ($ Million)
Table 2 Cancer Markers Used In Diagnosis And Treatment
Table 3 Population Aged 60 Years And Above
Table 4 Population Aged 80 Years And Above
Table 5 Countries With Utmost Aged Population
Table 6 Global Immunohistochemistry Market By Products 2018-2026 ($ Million)
Table 7 Global Immunohistochemistry Market In Antibodies By Geography 2018-2026 ($ Million)
Table 8 Incidence Of Diabetes In Major Countries, 2016 ($ Millions)
Table 9 Global Immunohistochemistry Market In Antibodies -2026 ($ Million)
Table 10 Global Antibodies Market In Primary Antibodies By Geography 2018-2026 ($ Million)
Table 11 Clinically Important Monoclonal Antibodies
Table 12 Global Antibodies Market In Secondary Antibodies Geography 2018-2026 ($ Million)
Table 13 Secondary Antibody Selection
Table 14 Global Immunohistochemistry Market In Equipment By Geography 2018-2026 ($ Million)
Table 15 Global Immunohistochemistry Market In Equipment 2018-2026 ($ Million)
Table 16 Global Equipment Market In Slide Staining Systems By Geography 2018-2026 ($ Million)
Table 17 Global Equipment Market In Tissue Microarrays By Geography 2018-2026 ($ Million)
Table 18 Global Equipment Market In Tissue Processing Systems By Geography 2018-2026 ($ Million)
Table 19 Healthcare Spending By High-income Countries By 2040
Table 20 Global Equipment Market In Slide Scanners By Geography 2018-2026 ($ Million)
Table 21 Global Equipment Market In Other Equipment’s By Geography 2018-2026 ($ Million)
Table 22 Global Immunohistochemistry Market In Reagents By Geography 2018-2026 ($ Million)
Table 23 Global Immunohistochemistry Market In Reagents 2018-2026 ($ Million)
Table 24 Global Reagents Market In Histological Stains By Geography 2018-2026 ($ Million)
Table 25 Histology Stains And Its Categories
Table 26 Global Reagents Market In Blocking Sera And Reagents By Geography 2018-2026 ($ Million)
Table 27 Global Reagents Market In Chromogenic Substrates By Geography 2018-2026 ($ Million)
Table 28 Global Reagents Market In Fixation Reagents By Geography 2018-2026 ($ Million)
Table 29 Common Fixatives And Their General Target Antigens
Table 30 Global Reagents Market In Stabilizers By Geography 2018-2026 ($ Million)
Table 31 Global Reagents Market In Organic Solvents By Geography 2018-2026 ($ Million)
Table 32 Global Reagents Market In Proteolytic Enzymes By Geography 2018-2026 ($ Million)
Table 33 Global Reagents Market In Diluents By Geography 2018-2026 ($ Million)
Table 34 Global Immunohistochemistry Market In Kits By Geography 2018-2026 ($ Million)
Table 35 Kit Components Are Available For Ihc Optimization
Table 36 Global Immunohistochemistry Market By Application 2018-2026 ($ Million)
Table 37 Global Immunohistochemistry Market In Diagnostic By Geography 2018-2026 ($ Million)
Table 38 Global Immunohistochemistry Market In Diagnostic 2018-2026 ($ Million)
Table 39 Global Diagnostic Market In Cancer By Geography 2018-2026 ($ Million)
Table 40 Global Diagnostic Market In Infectious Diseases By Geography 2018-2026 ($ Million)
Table 41 Global Diagnostic Market In Cardiovascular Disease By Geography 2018-2026 ($ Million)
Table 42 Global Diagnostic Market In Autoimmune Diseases By Geography 2018-2026 ($ Million)
Table 43 Selected Infectious Etiologies Of Autoimmune Diseases
Table 44 Global Diagnostic Market In Diabetes Mellitus By Geography 2018-2026 ($ Million)
Table 45 Global Diagnostic Market In Nephrological Diseases By Geography 2018-2026 ($ Million)
Table 46 Global Immunohistochemistry Market In Drug Testing By Geography 2018-2026 ($ Million)
Table 47 Global Immunohistochemistry Market By End-users 2018-2026 ($ Million)
Table 48 Global Immunohistochemistry Market In Hospitals And Diagnostic Laboratories By Geography 2018-2026 ($ Million)
Table 49 Global Immunohistochemistry Market In Research Institutes By Geography 2018-2026 ($ Million)
Table 50 Cancer Research Program
Table 51 Global Immunohistochemistry Market In Other End-users By Geography 2018-2026 ($ Million)
Table 52 Immunohistochemistry Usage In Forensic Pathology
Table 53 Antibodies Manufacturers In The Global Immunohistochemistry Market
Table 54 Global Immunohistochemistry Market By Geography 2018-2026 ($ Million)
Table 55 North America Immunohistochemistry Market 2018-2026 ($ Million)
Table 56 Fund Invested For Different Cancer Types (2017)
Table 57 Percent Distribution Of Projected New Cancer Cases (2017)
Table 58 Europe Immunohistochemistry Market 2018-2026 ($ Million)
Table 59 Number Of People Living And Dying With Cvd
Table 60 Number Of Deaths Caused By Cardiovascular Diseases In Germany 2016
Table 61 Diseases Causing Premature Death In Germany (2017)
Table 62 Asia Pacific Immunohistochemistry Market 2018-2026 ($ Million)
Table 63 Cancer Types Based On Incidence Rates (2016)
Table 64 Cancer Types Based On Mortality Rates (2016)
Table 65 Estimated Incidence Of All Cancers Combined By Sex (2017)
Table 66 Estimated Common Causes Of Death For Cancer (Males 2017)
Table 67 Estimated Common Causes Of Death For Cancer By Sex (Females 2017)
Table 68 Latin America Immunohistochemistry Market 2018-2026 ($ Million)
Table 69 Causes Of Death In Argentina In 2016
Table 70 Causes Of Death In Cuba 2016
Table 71 Rest Of World Immunohistochemistry Market 2018-2026 ($ Million)
Figures List
Figure 1 Global Immunohistochemistry Market 2018-2026 ($ Million)
Figure 2 Global Immunohistochemistry Market In Antibodies 2018-2026 ($ Million)
Figure 3 Global Immunohistochemistry Market In Equipment 2018-2026 ($ Million)
Figure 4 Global Immunohistochemistry Market In Reagents 2018-2026 ($ Million)
Figure 5 Phases Of Histological Staining
Figure 6 Global Immunohistochemistry Market In Kits 2018-2026 ($ Million)
Figure 7 Global Immunohistochemistry Market In Diagnostic 2018-2026 ($ Million)
Figure 8 Healthcare Expenditures Across The Globe (% Of Gdp)
Figure 9 Global Prevalence Of Chronic Kidney Diseases By Age
Figure 10 Global Immunohistochemistry Market In Drug Testing 2018-2026 ($ Million)
Figure 11 Incidence Of Patients With Chronic Diseases Globally 2005–2030
Figure 12 Global Immunohistochemistry Market In Hospitals And Diagnostic Laboratories 2018-2026 ($ Million)
Figure 13 Global Immunohistochemistry Market In Research Institutes 2018-2026 ($ Million)
Figure 14 Global Immunohistochemistry Market In Other End-users 2018-2026 ($ Million)
Figure 15 History Of Immunohistochemistry
Figure 16 North America Immunohistochemistry Market 2018-2026 ($ Million)
Figure 17 The United States Immunohistochemistry Market 2018-2026 ($ Million)
Figure 18 Canada Immunohistochemistry Market 2018-2026 ($ Million)
Figure 19 Europe Immunohistochemistry Market 2018-2026 ($ Million)
Figure 20 The United Kingdom Immunohistochemistry Market 2018-2026 ($ Million)
Figure 21 France Immunohistochemistry Market 2018-2026 ($ Million)
Figure 22 Germany Immunohistochemistry Market 2018-2026 ($ Million)
Figure 23 Spain Immunohistochemistry Market 2018-2026 ($ Million)
Figure 24 Italy Immunohistochemistry Market 2018-2026 ($ Million)
Figure 25 Russia Immunohistochemistry Market 2018-2026 ($ Million)
Figure 26 Rest Of Europe Immunohistochemistry Market 2018-2026 ($ Million)
Figure 27 Asia Pacific Immunohistochemistry Market 2018-2026 ($ Million)
Figure 28 China Immunohistochemistry Market 2018-2026 ($ Million)
Figure 29 India Immunohistochemistry Market 2018-2026 ($ Million)
Figure 30 Japan Immunohistochemistry Market 2018-2026 ($ Million)
Figure 31 South Korea Immunohistochemistry Market 2018-2026 ($ Million)
Figure 32 Australia Immunohistochemistry Market 2018-2026 ($ Million)
Figure 33 Rest Of Apac Immunohistochemistry Market 2018-2026 ($ Million)
Figure 34 Latin America Immunohistochemistry Market 2018-2026 ($ Million)
Figure 35 Brazil Immunohistochemistry Market 2018-2026 ($ Million)
Figure 36 Healthcare Spending In Mexico 2014 And 2040 ($ Billion)
Figure 37 Mexico Immunohistochemistry Market 2018-2026 ($ Million)
Figure 38 Healthcare Spending In Argentina 2014 And 2040 ($ Billion)
Figure 39 Argentina Immunohistochemistry Market 2018-2026 ($ Million)
Figure 40 Chile Immunohistochemistry Market 2018-2026 ($ Million)
Figure 41 Healthcare Expenditure In Chile 2005-2016 (Percentage Share Of Gdp)
Figure 42 Healthcare Spending In Cuba (2014 And 2040)
Figure 43 Cuba Immunohistochemistry Market 2018-2026 ($ Million)
Figure 44 Rest Of Latin America Immunohistochemistry Market 2018-2026 ($ Million)
Figure 45 Rest Of World Immunohistochemistry Market 2018-2026 ($ Million)
Figure 46 Middle East And North Africa Immunohistochemistry Market 2018-2026 ($ Million)
Figure 47 Rest Of Africa Immunohistochemistry Market 2018-2026 ($ Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report